Opportunity
Federal Register #DEA-1725
DEA Notice: Wedgewood Pharmacy LLC Application to Import Etorphine HCL and Thiafentanil
Buyer
Drug Enforcement Administration
Posted
June 17, 2026
Respond By
July 17, 2026
Identifier
DEA-1725
NAICS
424210
This opportunity concerns the Drug Enforcement Administration (DEA) notice regarding Wedgewood Pharmacy LLC's application to import controlled substances. - Government Buyer: - Department of Justice, Drug Enforcement Administration (DEA) - OEM/Vendor: - Wedgewood Pharmacy LLC - Products Requested: - Etorphine HCL (drug code 9059) - Thiafentanil (drug code 9729) - Both are Schedule II controlled substances - No specific quantities provided - Notable Requirements: - Importation is for distribution to customers only - Registration does not permit import of FDA-approved or non-approved finished dosage forms for commercial sale - No other activities for these drug codes are authorized under this registration - Public comments, objections, or hearing requests are invited regarding the application
Description
Wedgewood Pharmacy LLC has applied to be registered as an importer of basic classes of controlled substances, specifically Etorphine HCL and Thiafentanil, both Schedule II drugs. The company plans to import these substances for distribution to their customers. The registration does not authorize the import of FDA-approved or non-approved finished dosage forms for commercial sale. Comments or objections to the application can be submitted until July 17, 2026, and requests for a hearing must also be filed by this date.